000 01630 a2200421 4500
005 20250517094203.0
264 0 _c20170327
008 201703s 0 0 eng d
022 _a1878-1705
024 7 _a10.1016/j.intimp.2016.04.028
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPittini, Álvaro
245 0 0 _aPharmacological inhibition of PI3K class III enhances the production of pro- and anti-inflammatory cytokines in dendritic cells stimulated by TLR agonists.
_h[electronic resource]
260 _bInternational immunopharmacology
_cJul 2016
300 _a213-217 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAndrostadienes
_xpharmacology
650 0 4 _aAnimals
650 0 4 _aBone Marrow Cells
_xphysiology
650 0 4 _aCells, Cultured
650 0 4 _aClass I Phosphatidylinositol 3-Kinases
_xmetabolism
650 0 4 _aClass III Phosphatidylinositol 3-Kinases
_xantagonists & inhibitors
650 0 4 _aDendritic Cells
_xphysiology
650 0 4 _aGlycogen Synthase Kinase 3
_xmetabolism
650 0 4 _aInterleukin-10
_xmetabolism
650 0 4 _aInterleukin-12
_xmetabolism
650 0 4 _aLipopolysaccharides
_ximmunology
650 0 4 _aMice
650 0 4 _aMice, Inbred Strains
650 0 4 _aOncogene Protein v-akt
_xmetabolism
650 0 4 _aSignal Transduction
_xdrug effects
650 0 4 _aWortmannin
700 1 _aCasaravilla, Cecilia
700 1 _aAllen, Judith E
700 1 _aDíaz, Álvaro
773 0 _tInternational immunopharmacology
_gvol. 36
_gp. 213-217
856 4 0 _uhttps://doi.org/10.1016/j.intimp.2016.04.028
_zAvailable from publisher's website
999 _c26009535
_d26009535